Smartleaf Asset Management LLC Boosts Stake in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Smartleaf Asset Management LLC lifted its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 62.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,844 shares of the medical instruments supplier’s stock after acquiring an additional 706 shares during the period. Smartleaf Asset Management LLC’s holdings in Mesa Laboratories were worth $243,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. FMR LLC increased its position in shares of Mesa Laboratories by 34.1% during the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 100 shares during the last quarter. Quantbot Technologies LP purchased a new stake in Mesa Laboratories in the third quarter worth approximately $70,000. Amalgamated Bank grew its position in Mesa Laboratories by 6.5% during the third quarter. Amalgamated Bank now owns 1,588 shares of the medical instruments supplier’s stock valued at $206,000 after acquiring an additional 97 shares during the last quarter. Captrust Financial Advisors bought a new stake in shares of Mesa Laboratories in the 3rd quarter worth approximately $207,000. Finally, Berry Wealth Group LP boosted its stake in shares of Mesa Laboratories by 5.3% in the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier’s stock valued at $219,000 after purchasing an additional 83 shares in the last quarter. 90.60% of the stock is currently owned by hedge funds and other institutional investors.

Mesa Laboratories Stock Up 1.0 %

Shares of Mesa Laboratories stock opened at $137.55 on Thursday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71. The company’s 50 day moving average price is $139.99 and its 200-day moving average price is $129.56. The stock has a market capitalization of $747.45 million, a price-to-earnings ratio of -2.97 and a beta of 0.83. Mesa Laboratories, Inc. has a 52-week low of $83.68 and a 52-week high of $155.12.

Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. Equities research analysts forecast that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, February 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Friday, February 28th. Mesa Laboratories’s payout ratio is -1.38%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.